Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

Mise à jour : Il y a 4 ans
Référence : NCT01328379

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to investigate the safety and efficacy of a lower dose of dalfampridine extended release tablets compared to the currently approved dose in improving walking in Multiple Sclerosis (MS) patients.


Critère d'inclusion

  • Multiple sclerosis

Liens